In a recent discussion between Sanjay Motwani Artemis’ GM, Matt Grapentine of Mercer, Leah Motl of Holmes Murphy, and Kerry Gross Arizent’s Director of Research Intelligence, benefits leaders reacted to the results of our annual study that identified the top goals and pain points in the benefits space.
When It Comes to Specialty Drugs, Location Matters
Are you spending wisely on specialty drugs? Used to treat chronic and severe illnesses, specialty drugs often need special handling or administration.
Cost Advisor: The New Timesaving Tool for Easy Monthly Reporting
Artemis Cost Advisor takes care of the monthly busy work of financial reporting so brokers can spend more time on their specialty, providing consultative advice and sound benefits recommendations for their clients
Elevate 2022 | How Analytics are Boldly Reshaping Healthcare
After a long pause due to the pandemic, Artemis has brought back the exclusive, much-anticipated annual customer conference with this year’s Elevate 2022.
Three Real-World Use Cases for Artemis Console, Our Program Evaluation Tool
Point solutions are the talk of the benefits industry this year, with dozens of vendors for any condition you can think of. We’ll explore three use cases of how employers and advisors are evaluating point solutions with Artemis Console.
How Brokers and Consultants Are Helping Employers in the Fight for Talent
The Great Resignation continues to be a concern for self-insured employers in the first months of 2022. In this piece, we explore how brokers and consultants can help craft a benefits strategy that helps reduce employee turnover.
Healthcare State of the Union: Challenges and Trends in U.S. Healthcare
What is the current healthcare state of the union? What are some of the greatest challenges and trends impacting self-insured employers? We sat down with Sanjay Motwani, Chief Product Development Officer at Artemis Health, for some insights.